Healthcare professional in PPE washing hands to show Janssen's COVID-19 vaccine trial to commence in July

Janssen’s COVID-19 vaccine trial to commence in July

Janssen's COVID-19 vaccine trial is to commence in the second half of July, earlier than expected. Johnson & Johnson has announced that through its...
Image of a doctor with a stethoscope to show Public reassurance needed over slow road to NHS recovery

Public reassurance needed over slow road to NHS recovery

The NHS faces a slow road to recovery and the Government must manage expectations to retain public confidence. That is the message from the NHS...
Image of coronavirus to chow New study trials use of CT-P13 to accelerate COVID-19 recovery

New study trials use of CT-P13 to accelerate COVID-19 recovery

Celltrion Healthcare is partnering with the University of Oxford and University Hospitals Birmingham to study the use of CT-P13 (biosimilar infliximab) to accelerate COVID-19...
Image of a healthcare professional with a face mask to show Lilly announces start of a Phase 1 study for its second potential COVID-19 antibody treatment

Lilly announces start of a Phase 1 study for its second potential COVID-19 antibody...

Eli Lilly and Company announced that its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralising COVID-19...
Image of a woman and man shaking hands in front of a contract to show New partnership to drive viral vector vaccine manufacturing including COVID-19

New partnership to drive viral vector vaccine manufacturing including COVID-19 vaccine

The Vaccines Manufacturing and Innovation Centre (VMIC) has signed its first industry partnership agreement with Oxford Biomedica plc. The organisations will collaborate to enable...
image of a syringe and coronavirus to show Peptide vaccine against COVID-19 in development

Peptide vaccine against COVID-19 in development

Independent clinical-stage biotech AXON Neuroscience has announced it has a promising peptide vaccine against COVID-19 in development. Axon has announced its development of COVIDAX, a...
Image of magnifying glass over coronavirus to show Trial tests a unique formulation of ibuprofen to treat COVID-19

Trial tests a unique ibuprofen formulation to treat COVID-19

A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS), a complication of COVID-19, has launched in...
Image of coronavirus to show Lilly begins world’s first study of a potential COVID-19 antibody treatment in humans

Lilly begins world’s first study of a potential COVID-19 antibody treatment in humans

Eli Lilly and Company has announced that patients have been dosed in the world’s first study of a potential COVID-19 antibody treatment designed to...
Image of test tubes with different coloured liquids to show Positive results for Celltrion's COVID-19 antiviral antibody treatment

Positive results for Celltrion’s COVID-19 antiviral antibody treatment

Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of...
Image of a compass with a doctor standing in the middle and a patient pushing the direction to show From HIV to COVID-19: Charting the path of patient power

From HIV to COVID-19: Charting the path of patient power

Patient power has evolved considerably since it was born to represent the voiceless during the 1980s HIV/AIDS crisis. Will COVID-19 provide the movement with...

Latest articles

Partnership announced to fight against counterfeit drugs

Partnership announced to fight against counterfeit drugs

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a contract and pen to show WAYLIVRA ▼® (volanesorsen) for FCS to be available on the NHS in England

WAYLIVRA▼® (volanesorsen) for FCS to be available on the NHS in England

The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for WAYLIVRA▼® (volanesorsen), the first and only therapy for adults...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Star OUTiCO

Healthcare service providers Star Medical and OUTiCO merge to create new brand identity

Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry and part of the global Uniphar Group, has launched...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription